Several other research firms also recently commented on CERN. Zacks Investment Research downgraded Cerner from a buy rating to a hold rating in a report on Thursday, January 4th. Cantor Fitzgerald raised their price objective on Cerner to $83.00 and gave the stock an overweight rating in a report on Friday, January 5th. BidaskClub downgraded Cerner from a buy rating to a hold rating in a report on Friday, December 22nd. Bank of America began coverage on Cerner in a report on Tuesday, February 27th. They set a buy rating and a $75.00 price objective on the stock. Finally, Citigroup began coverage on Cerner in a report on Thursday, January 4th. They set a neutral rating on the stock. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and ten have assigned a buy rating to the company’s stock. Cerner has a consensus rating of Hold and an average target price of $67.87.
Shares of CERN stock opened at $58.00 on Friday. Cerner has a 52-week low of $56.49 and a 52-week high of $73.86. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.01 and a quick ratio of 2.99. The company has a market cap of $19,290.63, a P/E ratio of 26.36, a price-to-earnings-growth ratio of 1.69 and a beta of 0.93.
In related news, Director William D. Zollars sold 4,100 shares of the business’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $62.16, for a total transaction of $254,856.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Jeffrey A. Townsend sold 230,000 shares of the business’s stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $61.94, for a total value of $14,246,200.00. The disclosure for this sale can be found here. Insiders sold a total of 541,800 shares of company stock worth $34,353,860 over the last quarter. Company insiders own 13.11% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the stock. BlackRock Inc. grew its stake in Cerner by 2.2% during the 4th quarter. BlackRock Inc. now owns 19,519,304 shares of the company’s stock worth $1,315,406,000 after buying an additional 420,942 shares during the last quarter. Capital International Investors grew its stake in Cerner by 0.3% during the 3rd quarter. Capital International Investors now owns 4,851,296 shares of the company’s stock worth $345,994,000 after buying an additional 12,178 shares during the last quarter. Geode Capital Management LLC grew its stake in Cerner by 2.7% during the 4th quarter. Geode Capital Management LLC now owns 3,759,894 shares of the company’s stock worth $252,916,000 after buying an additional 98,444 shares during the last quarter. American Century Companies Inc. grew its stake in Cerner by 3.7% during the 4th quarter. American Century Companies Inc. now owns 3,204,461 shares of the company’s stock worth $215,949,000 after buying an additional 114,224 shares during the last quarter. Finally, Guggenheim Capital LLC grew its stake in Cerner by 25.5% during the 4th quarter. Guggenheim Capital LLC now owns 1,121,984 shares of the company’s stock worth $75,611,000 after buying an additional 227,626 shares during the last quarter. Hedge funds and other institutional investors own 78.54% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was first reported by WKRB News and is the property of of WKRB News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this story can be accessed at https://www.wkrb13.com/2018/04/01/wells-fargo-analysts-give-cerner-cern-a-75-00-price-target.html.
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.